Skip to main content
Dr Philip Pallmann

Dr Philip Pallmann

Deputy Director Research Design and Conduct Service and Research Fellow

+44 (0)29 2068 7461
505, 5th floor, Neuadd Meirionnydd, University Hospital of Wales, Heath Park, Cardiff, CF14 4YS
Available for postgraduate supervision


Education and qualifications

  • 2016: PhD Biostatistics, Leibniz Universität Hannover
  • 2012: MSc Plant Biotechnology, Leibniz Universität Hannover
  • 2010: BSc Plant Biotechnology, Leibniz Universität Hannover

Honours and awards

  • 2013: Bernd Streitberg Award of the International Biometric Society (German Region) for my MSc dissertation Two-sample tests and multiple contrast tests of several diversity indices
  • 2012: Second Prize for Best Student Oral Presentation at the 36th International Biometric Conference in Kobe, Japan

Professional memberships

  • Adaptive Designs Working Group, MRC Network of Hubs for Trials Methodology Research
  • European Huntington's Disease Network

Academic positions

  • 2017 - present: Research Fellow & RDCS Deputy Director, Centre for Trials Research, Cardiff University
  • 2015 - 2017: Senior Research Associate, Department of Mathematics & Statistics, Lancaster University
  • 2012 - 2015: Research Associate, Institute of Biostatistics, Leibniz Universität Hannover
  • 2010 - 2012: Research Assistant, Institute of Biostatistics, Leibniz Universität Hannover
  • 2009 - 2010: Teaching Assistant, Institute of Plant Diseases and Plant Protection, Leibniz Universität Hannover

Committees and reviewing

  • Independent Trial Steering Committee member: PLAN-AEmpathicaNOTACS (currently); AML18/19/LI1 (previously)
  • Independent Data Monitoring Committee member: CANTOP-RCT
  • Grant application and final report reviewer for various NIHR programmes (HTA, EME, PHR, HS&DR)
  • Grant application reviewer for MRC Biomedical Catalyst DPFS
  • Grant application reviewer for HCRW Pathway to Portfolio
  • Associate Editor for Trials
  • Manuscript reviewer for journals including Trials, Clinical Trials, PLOS One, Statistics in Medicine, Journal of Statistical Software, Biometrical Journal, The AAPS Journal, Statistical Methods in Medical Research, Statistics, Journal of Applied Statistics, Journal of Biopharmaceutical Statistics, Journal of Computational & Graphical Statistics, Statistica Neerlandica, Frontiers in Neurology, Contemporary Clinical Trials, The British Student Doctor Journal, Pest Management Science, Environmental Science & Pollution Research (see my Publons profile)
  • Abstract reviewer for ESPID 38th Annual Meeting 2020











Summary of my research

I currently work on a number of clinical trials including BATCH, PRONTOTRIDENTFLAME, TAPERS, SaFEDocTIS, PRECISE and DOMINO-HD.

I have been actively involved in the ACE Project to develop an official CONSORT extension for clinical trials with an adaptive design, the PANDA Project to create an educational online platform about adaptive designs, and the CAT Project to develop best practice costing guidance for CTUs supporting adaptive design trials.

I am a member of the Adaptive Designs Working Group of the MRC Network of Hubs for Trials Methodology Research.

I have (co-)authored and/or am the maintainer of a number of R packages that are freely available on CRAN, including MAMS (multi-arm multi-stage studies), BayesMAMS (Bayesian multi-arm multi-stage studies), jocre (joint confidence regions), modest (model-based dose-escalation trials), ANOM (analysis of means) and simboot (simultaneous inference for diversity indices).

Recently awarded grant funding


  • HCRW Clinical Trials Unit Infrastructure Funding: Centre for Trials Research 2020-23 (£2,470,489)
  • MRC CTU Support Funding: Costing adaptive trials (CAT): developing best practice costing guidance for CTUs supporting adaptive trials (£55,629)
  • NIHR HTA: Procalcitonin and NEWS evaluation for timely identification of sepsis and optimal use of antibiotics in the emergency department (PRONTO) (£1,968,786)
  • NIHR PHR: Optimisation, feasibility testing and a pilot randomised trial of SaFE: a sexual health and healthy relationships intervention for Further Education (£510,815)
  • EU H2020: Decision on optimal combinatorial therapies in IMIDs using systems approaches (DocTIS) (€6,260,050)


  • EU JPND Research: Multi-domain lifestyle targets for improving prognosis in Huntington's disease (DOMINO-HD) (€2,057,969)
  • MRC CTU Support Funding: A practical adaptive and novel designs toolkit (PANDA) (£98,886)
  • HCRW RfPPB: Treating anxiety to prevent relapse in schizophrenia (TAPERS) – a feasibility trial (£229,865)


Current supervision

A Markoulidakis

Andreas Markoulidakis

Research student